BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 29942976)

  • 1. Targeting glutaminase-mediated glutamine dependence in papillary thyroid cancer.
    Yu Y; Yu X; Fan C; Wang H; Wang R; Feng C; Guan H
    J Mol Med (Berl); 2018 Aug; 96(8):777-790. PubMed ID: 29942976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.
    Lampa M; Arlt H; He T; Ospina B; Reeves J; Zhang B; Murtie J; Deng G; Barberis C; Hoffmann D; Cheng H; Pollard J; Winter C; Richon V; Garcia-Escheverria C; Adrian F; Wiederschain D; Srinivasan L
    PLoS One; 2017; 12(9):e0185092. PubMed ID: 28950000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.
    Mukha A; Kahya U; Linge A; Chen O; Löck S; Lukiyanchuk V; Richter S; Alves TC; Peitzsch M; Telychko V; Skvortsov S; Negro G; Aschenbrenner B; Skvortsova II; Mirtschink P; Lohaus F; Hölscher T; Neubauer H; Rivandi M; Labitzky V; Lange T; Franken A; Behrens B; Stoecklein NH; Toma M; Sommer U; Zschaeck S; Rehm M; Eisenhofer G; Schwager C; Abdollahi A; Groeben C; Kunz-Schughart LA; Baretton GB; Baumann M; Krause M; Peitzsch C; Dubrovska A
    Theranostics; 2021; 11(16):7844-7868. PubMed ID: 34335968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAG3 promotes autophagy and glutaminolysis via stabilizing glutaminase.
    Zhao S; Wang JM; Yan J; Zhang DL; Liu BQ; Jiang JY; Li C; Li S; Meng XN; Wang HQ
    Cell Death Dis; 2019 Mar; 10(4):284. PubMed ID: 30910998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Glutaminolysis Inhibits Cell Growth via Down-regulating Mtorc1 Signaling in Lung Squamous Cell Carcinoma.
    Ye X; Zhou Q; Matsumoto Y; Moriyama M; Kageyama S; Komatsu M; Satoh S; Tsuchida M; Saijo Y
    Anticancer Res; 2016 Nov; 36(11):6021-6029. PubMed ID: 27793929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging Reduces an ERRalpha-Directed Mitochondrial Glutaminase Expression Suppressing Glutamine Anaplerosis and Osteogenic Differentiation of Mesenchymal Stem Cells.
    Huang T; Liu R; Fu X; Yao D; Yang M; Liu Q; Lu WW; Wu C; Guan M
    Stem Cells; 2017 Feb; 35(2):411-424. PubMed ID: 27501743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mTORC1/S6K1 pathway regulates glutamine metabolism through the eIF4B-dependent control of c-Myc translation.
    Csibi A; Lee G; Yoon SO; Tong H; Ilter D; Elia I; Fendt SM; Roberts TM; Blenis J
    Curr Biol; 2014 Oct; 24(19):2274-80. PubMed ID: 25220053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERK5 Interacts with Mitochondrial Glutaminase and Regulates Its Expression.
    Guillén-Pérez YM; Ortiz-Ruiz MJ; Márquez J; Pandiella A; Esparís-Ogando A
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamine, MTOR and autophagy: a multiconnection relationship.
    Bodineau C; Tomé M; Murdoch PDS; Durán RV
    Autophagy; 2022 Nov; 18(11):2749-2750. PubMed ID: 35470752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disrupting porcine glutaminase does not block preimplantation development and elongation nor decrease mTORC1 activation in conceptuses†.
    Chen PR; Lucas CG; Cecil RF; Pfeiffer CA; Fudge MA; Samuel MS; Zigo M; Seo H; Spate LD; Whitworth KM; Sutovsky P; Johnson GA; Wells KD; Geisert RD; Prather RS
    Biol Reprod; 2021 Nov; 105(5):1104-1113. PubMed ID: 34453429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUCLA2-coupled regulation of GLS succinylation and activity counteracts oxidative stress in tumor cells.
    Tong Y; Guo D; Lin SH; Liang J; Yang D; Ma C; Shao F; Li M; Yu Q; Jiang Y; Li L; Fang J; Yu R; Lu Z
    Mol Cell; 2021 Jun; 81(11):2303-2316.e8. PubMed ID: 33991485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers.
    Shen YA; Hong J; Asaka R; Asaka S; Hsu FC; Suryo Rahmanto Y; Jung JG; Chen YW; Yen TT; Tomaszewski A; Zhang C; Attarwala N; DeMarzo AM; Davidson B; Chuang CM; Chen X; Gaillard S; Le A; Shih IM; Wang TL
    Cancer Res; 2020 Oct; 80(20):4514-4526. PubMed ID: 32859605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Myc Overexpression Promotes Oral Cancer Cell Proliferation and Migration by Enhancing Glutaminase and Glutamine Synthetase Activity.
    Wang T; Cai B; Ding M; Su Z; Liu Y; Shen L
    Am J Med Sci; 2019 Sep; 358(3):235-242. PubMed ID: 31324362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-137 inhibits glutamine catabolism and growth of malignant melanoma by targeting glutaminase.
    Luan W; Zhou Z; Zhu Y; Xia Y; Wang J; Xu B
    Biochem Biophys Res Commun; 2018 Jan; 495(1):46-52. PubMed ID: 29097210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional antitumor molecule 5'-triphosphate siRNA combining glutaminase silencing and RIG-I activation.
    Meng G; Xia M; Xu C; Yuan D; Schnurr M; Wei J
    Int J Cancer; 2014 Apr; 134(8):1958-71. PubMed ID: 23921958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mTOR Kinase Inhibitor CZ415 Inhibits Human Papillary Thyroid Carcinoma Cell Growth.
    Li X; Li Z; Song Y; Liu W; Liu Z
    Cell Physiol Biochem; 2018; 46(2):579-590. PubMed ID: 29617677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LincRNA-p21 suppresses glutamine catabolism and bladder cancer cell growth through inhibiting glutaminase expression.
    Zhou Q; Zhan H; Lin F; Liu Y; Yang K; Gao Q; Ding M; Liu Y; Huang W; Cai Z
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30902882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2.
    Xiao D; Ren P; Su H; Yue M; Xiu R; Hu Y; Liu H; Qing G
    Oncotarget; 2015 Dec; 6(38):40655-66. PubMed ID: 26528759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [
    Zhou R; Pantel AR; Li S; Lieberman BP; Ploessl K; Choi H; Blankemeyer E; Lee H; Kung HF; Mach RH; Mankoff DA
    Cancer Res; 2017 Mar; 77(6):1476-1484. PubMed ID: 28202527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of glutaminase 1 resensitizes Taxol-resistant breast cancer cells to Taxol.
    Fu A; Yu Z; Song Y; Zhang E
    Mol Med Rep; 2015 Jun; 11(6):4727-33. PubMed ID: 25625774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.